ストックスクリーナーアプリを入手
143.94
2.94%
-4.36
前日終値:
$148.30
開ける：
$147.19
24時間の取引高:
1.26M
Relative Volume:
0.82
時価総額：
$20.05B
収益：
$1.53B
当期純損益:
$-214.69M
株価収益率:
-81.78
EPS:
-1.76
ネットキャッシュフロー:
$-43.68M
1週間 パフォーマンス:
-4.77%
1か月 パフォーマンス:
-8.09%
6か月 パフォーマンス:
+14.49%
1年 パフォーマンス:
+57.38%
1日の値動き範囲:
$141.11
$148.99
1週間の範囲:
$141.11
$155.64
52週間の値動き範囲:
$83.13
$183.00
Natera Inc Stock (NTRA) Company Profile
NTRA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
NTRA
Natera Inc
|
143.94 | 20.05B | 1.53B | -214.69M | -43.68M | -1.76 |
|
TMO
Thermo Fisher Scientific Inc
|
500.16 | 196.14B | 42.88B | 6.34B | 7.27B | 16.53 |
|
DHR
Danaher Corp
|
205.85 | 150.17B | 23.88B | 3.90B | 5.30B | 5.28 |
|
IDXX
Idexx Laboratories Inc
|
415.87 | 34.36B | 3.90B | 887.87M | 798.08M | 10.67 |
|
A
Agilent Technologies Inc
|
116.69 | 33.28B | 6.53B | 1.26B | 1.31B | 4.35 |
|
IQV
Iqvia Holdings Inc
|
177.39 | 31.62B | 15.41B | 1.37B | 2.11B | 7.50 |
Natera Inc Stock (NTRA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-03-13 | 開始されました | RBC Capital Mkts | Outperform |
| 2025-01-23 | 開始されました | Barclays | Overweight |
| 2024-06-03 | 再開されました | Jefferies | Buy |
| 2024-04-08 | 再開されました | Craig Hallum | Buy |
| 2024-02-20 | ダウングレード | Raymond James | Strong Buy → Outperform |
| 2023-12-29 | 繰り返されました | BTIG Research | Buy |
| 2023-12-14 | 開始されました | Guggenheim | Buy |
| 2023-12-13 | 開始されました | Wolfe Research | Outperform |
| 2023-11-13 | アップグレード | Raymond James | Outperform → Strong Buy |
| 2023-09-28 | 開始されました | Bernstein | Mkt Perform |
| 2023-07-05 | 再開されました | JP Morgan | Overweight |
| 2023-05-05 | 開始されました | UBS | Buy |
| 2023-01-18 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2022-08-25 | 開始されました | Credit Suisse | Outperform |
| 2022-04-25 | 開始されました | Stephens | Overweight |
| 2022-03-08 | 開始されました | Goldman | Buy |
| 2022-01-06 | 再開されました | Piper Sandler | Overweight |
| 2021-10-15 | 再開されました | Cowen | Outperform |
| 2021-06-15 | 開始されました | Raymond James | Mkt Perform |
| 2021-05-25 | 開始されました | Wells Fargo | Overweight |
| 2021-01-28 | 開始されました | Truist | Buy |
| 2020-10-08 | 開始されました | BTIG Research | Buy |
| 2020-09-28 | 開始されました | Morgan Stanley | Overweight |
| 2020-09-17 | 開始されました | SVB Leerink | Outperform |
| 2020-06-10 | 再開されました | Piper Sandler | Overweight |
| 2020-05-07 | アップグレード | JP Morgan | Neutral → Overweight |
| 2018-10-05 | 開始されました | JP Morgan | Neutral |
| 2018-07-05 | 繰り返されました | Piper Jaffray | Overweight |
| 2017-08-07 | 繰り返されました | Morgan Stanley | Overweight |
| 2016-11-10 | 繰り返されました | The Benchmark Company | Buy |
| 2016-05-23 | 繰り返されました | The Benchmark Company | Buy |
| 2016-05-11 | 繰り返されました | The Benchmark Company | Buy |
| 2016-04-19 | 開始されました | The Benchmark Company | Buy |
| 2015-09-28 | アップグレード | Wedbush | Neutral → Outperform |
| 2015-08-14 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2015-08-04 | 開始されました | Robert W. Baird | Outperform |
| 2015-07-27 | 開始されました | Morgan Stanley | Equal-Weight |
| 2015-07-27 | 開始されました | Piper Jaffray | Overweight |
| 2015-07-27 | 開始されました | Wedbush | Neutral |
すべてを表示
Natera Inc (NTRA) 最新ニュース
DEFINE-HT Selected for Late-Breaking Oral Presentation at ISHLT Annual Meeting - Yahoo Finance
Natera’s Busy 2025 Continues - The Healthcare Technology Report.
(PDF) Understanding the clinical genetics of kidney stone disease using the Natera Renasight panel - ResearchGate
Is Natera, Inc. (NTRA) the Best Diagnostics Stock to Invest in Right Now? - Insider Monkey
Natera Investors Get Class Status in Prenatal Screening Lawsuit - Bloomberg Law
Guardant Health gains amid $292.5M verdict against Natera over false advertising claims (update) - MSN
Natera CFO Michael Burkes sells $115,661 in company stock By Investing.com - Investing.com South Africa
Here’s What Lifted Natera (NTRA) in Q4 and 2024 - MSN
Natera’s president John Fesko sells $116,099 in stock By Investing.com - Investing.com Canada
Natera (NASDAQ:NTRA) Q4 Earnings: Leading The Immuno-Oncology Pack - Yahoo Finance
Natera’s chief legal officer sells $135,521 in stock By Investing.com - Investing.com Canada
Natera president sells $149,835 in stock By Investing.com - Investing.com Canada
Natera’s executive chairman sells $164,583 in stock By Investing.com - Investing.com Canada
Natera CEO Chapman sells $978,677 in company stock By Investing.com - Investing.com South Africa
Natera co-founder Sheena Jonathan sells $856,410 in stock By Investing.com - Investing.com South Africa
Natera president sells $149,835 in stock - Investing.com India
Natera’s chief legal officer sells $135,521 in stock - Investing.com India
Natera Executives and Directors Sell Shares to Cover Tax Obligations - TradingView
Natera CFO Michael Burkes sells $115,661 in company stock - Investing.com
Natera CEO Chapman sells $978,677 in company stock - Investing.com
Natera’s president John Fesko sells $116,099 in stock - Investing.com
Natera co-founder Sheena Jonathan sells $856,410 in stock - Investing.com India
Natera’s executive chairman sells $164,583 in stock - Investing.com India
Is Natera (NTRA) the Best Biotech Stock According to Billionaires? - Yahoo Finance
Judge Connolly (D. Del.) Overturns $96 Million Molecular Diagnostics Jury Verdict, Finds Patents Invalid Under § 112 - JD Supra
Is Natera, Inc. (NTRA) a Best Biotech Stock According to Billionaires? - Insider Monkey
Natera: Strong Growth Trajectory Despite Stretched Valuation Metrics (NASDAQ:NTRA) - Seeking Alpha
Natera Inc.: Strong Execution in Revenue Per Test Powering Our Optimism! - Smartkarma
Natera: Solid Execution, Pricey Stock (NASDAQ:NTRA) - Seeking Alpha
Natera: Growth Looks Unstoppable, Positive EPS Just A Matter Of Time - Seeking Alpha
Natera Inc (NTRA) Stock Price Up 4.01% on Mar 17 - GuruFocus.com
Natera initiated with an Outperform at RBC Capital - MSN
Natera Sees Unusually Large Options Volume (NASDAQ:NTRA) - Defense World
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Natera, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – NTRA - Business Wire
RBC Capital initiates Exact Sciences with Sector Perform, Natera with Outperform - MSN
INVESTOR DEADLINE: Natera, Inc. Investors with Substantial Losses Have Opportunity to Lead Natera Class Action Lawsuit – NTRA - Business Wire
Natera director Marcus Gail Boxer sells $590,773 in stock By Investing.com - Investing.com South Africa
Natera executive chairman sells $7.39 million in stock By Investing.com - Investing.com Canada
Natera director Marcus Gail Boxer sells $590,773 in stock - Investing.com India
Natera executive chairman sells $7.39 million in stock - Investing.com
Natera And 2 Other Stocks That May Be Trading Below Their Estimated Value - Simply Wall St
Natera, Inc. (NASDAQ:NTRA) Given Consensus Recommendation of “Buy” by Brokerages - Defense World
RBC Capital Initiates Coverage of Natera (NTRA) with Outperform Recommendation - Nasdaq
Natera (NasdaqGS:NTRA) Welcomes Former National Cancer Institute Director Back to Board - Simply Wall St
Natera Inc (NTRA) 財務データ
収益
当期純利益
現金流量
EPS
Natera Inc (NTRA) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Mar 17 '25 |
Sale |
146.04 |
792 |
115,661 |
71,869 |
| Sheena Jonathan | CO-FOUNDER |
Mar 18 '25 |
Sale |
145.65 |
3,000 |
436,952 |
41,782 |
| Sheena Jonathan | CO-FOUNDER |
Mar 18 '25 |
Sale |
145.57 |
2,700 |
393,027 |
258,319 |
| Sheena Jonathan | CO-FOUNDER |
Mar 17 '25 |
Sale |
146.03 |
181 |
26,431 |
261,019 |
| Rabinowitz Matthew | EXECUTIVE CHAIRMAN |
Mar 17 '25 |
Sale |
146.04 |
1,127 |
164,584 |
2,364,288 |
| RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER |
Mar 17 '25 |
Sale |
146.04 |
928 |
135,521 |
224,185 |
| Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS |
Mar 17 '25 |
Sale |
146.04 |
1,026 |
149,836 |
144,782 |
| Fesko John | PRESIDENT, CHIEF BUS. OFFICER |
Mar 17 '25 |
Sale |
146.04 |
795 |
116,099 |
157,289 |
0.71%
0.80%
大文字化:
|
ボリューム (24 時間):